NEW YORK, NY -- (Marketwired) -- 04/23/15 -- Taglich Brothers, Inc. is pleased to announce that XRpro Sciences, Inc. will be presenting at our 12th Annual Investment Conference May 5, 2015 in New York City. To view the webcast visit http://www.taglichbrothers.com/conference/conferencewebcast.php.
About Taglich Brothers
Taglich Brothers, Inc. is a full-service broker dealer focused exclusively on microcap companies. The Company defines the microcap segment of the equity market as companies with less than $250 million in market capitalization. Taglich Brothers currently offers institutional and retail brokerage services, investment banking and comprehensive research coverage to the investment community.
About XRpro Sciences, Inc.
XRpro Sciences, Inc. provides a unique platform for drug discovery and development services featuring high throughput ion channel assays for the pharmaceutical industry. The Company's proprietary advances in X-ray fluorescence provide measurements that would otherwise be difficult or impossible applying other readily available technologies. XRpro® technology directly measures the activity of a drug target, without the need for costly and artifact-causing chemical dyes or radiolabels. For further information, please visit www.xrpro.com.
Source: XRpro Sciences, Inc.